Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease—a cohort study
The high prevalence of ID highlights the importance of regular follow-up and proactive iron management. The results indicate that more women with type 1 and 2 VWD may require von Willebrand factor concentrate, despite it generally being considered a last-line treatment. The loss to follow-up observed in a substantial proportion of women underscores the need for improved long-term care strategies to prevent complications.
Authors
- Linda Myrin Westesson (ORCID: https://orcid.org/0000-0002-9613-8084)
- Petra Elfvinge
- Eva Zetterberg (ORCID: https://orcid.org/0000-0003-1775-1727)
- Anna Olsson (ORCID: https://orcid.org/0000-0002-9974-4880)
Institutions
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102949
- Citations
- 5
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.85
Funders
- CSL Behring